Urinary liver-type fatty acid-binding protein increases with levels of albuminuria in type 1 diabetic patients, and is reduced with ACE inhibition

被引：0
|
作者：
Nielsen, S. [1 ]
Sugaya, T. [2 ]
Tarnow, L. [1 ]
Schjoedt, K. J. [1 ]
Astrup, A. S. [1 ]
Baba, T. [3 ]
Parving, H. -H. [4 ]
Rossing, P. [1 ]
机构：
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] St Marianna Univ, Sch Med, Kanagawa, Japan
[3] Fukushima Med Univ, Fukushima, Japan
[4] Copenhagen Univ Hosp, Rigshosp, Dept Med Endocrinol, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
46
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [1] Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
    Nielsen, Stine Elkjaer
    Sugaya, Takeshi
    Hovind, Peter
    Baba, Tsuneharu
    Parving, Hans-Henrik
    Rossing, Peter
    [J]. DIABETES CARE, 2010, 33 (06) : 1320 - 1324
  • [2] Urinary Liver-Type Fatty Acid-Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
    Panduru, Nicolae M.
    Forsblom, Carol
    Saraheimo, Markku
    Thorn, Lena
    Bierhaus, Angelika
    Humpert, Per M.
    Groop, Per-Henrik
    [J]. DIABETES CARE, 2013, 36 (07) : 2077 - 2083
  • [3] Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy
    Nakamura, T
    Sugaya, T
    Kawagoe, Y
    Ueda, Y
    Osada, S
    Koide, H
    [J]. DIABETES CARE, 2005, 28 (11) : 2728 - 2732
  • [4] Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy
    Suzuki, K
    Babazono, T
    Murata, H
    Iwamoto, Y
    [J]. DIABETES CARE, 2005, 28 (08) : 2038 - 2039
  • [5] Clinical Significance of Urinary Liver-Type Fatty Acid-Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
    Kamijo-Ikemori, Atsuko
    Sugaya, Takeshi
    Yasuda, Takashi
    Kawata, Takehiro
    Ota, Akio
    Tatsunami, Shinobu
    Kaise, Ruriko
    Ishimitsu, Toshihiko
    Tanaka, Yasushi
    Kimura, Kenjiro
    [J]. DIABETES CARE, 2011, 34 (03) : 691 - 696
  • [6] The Role of Urinary Liver-Type Fatty Acid-Binding Protein in Critically Ill Patients
    Cho, Eunjung
    Yang, Ha Na
    Jo, Sang-Kyung
    Cho, Won-Yong
    Kim, Hyoung-Kyu
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (01) : 100 - 105
  • [7] Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia
    Imai, Naohiko
    Yasuda, Takashi
    Kamijo-Ikemori, Atsuko
    Shibagaki, Yugo
    Kimura, Kenjiro
    [J]. PLOS ONE, 2015, 10 (05):
  • [8] Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis
    Zhang, Li
    Xue, Shuai
    Wu, Meiyan
    Dong, Dan
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [9] Urinary Fatty Acids and Liver-Type Fatty Acid Binding Protein in Diabetic Nephropathy
    Sasaki, Hiroyo
    Kamijo-Ikemori, Atsuko
    Sugaya, Takeshi
    Yamashita, Kayoko
    Yokoyama, Takeshi
    Koike, Jyunki
    Sato, Takeo
    Yasuda, Takashi
    Kimura, Kenjiro
    [J]. NEPHRON CLINICAL PRACTICE, 2009, 112 (03): : C148 - C156
  • [10] Cigarette smoking affects urinary liver-type fatty acid-binding protein concentration in patients with early diabetic nephropathy
    Nakamura, Tsukasa
    Sugaya, Takeshi
    Koide, Hikaru
    [J]. DIABETES CARE, 2006, 29 (07) : 1717 - 1717
12345